A66

CAS No. 1166227-08-2

A66 ( A 66; A-66 )

Catalog No. M10568 CAS No. 1166227-08-2

A66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 42 In Stock
5MG 69 In Stock
10MG 114 In Stock
25MG 221 In Stock
50MG 389 In Stock
100MG 575 In Stock
500MG 1197 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    A66
  • Note
    Research use only, not for human use.
  • Brief Description
    A66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor.
  • Description
    A66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor with IC50 of 32, 30 and 43 nM for wt p110α, p110α E545K and p110α H1047R, respectively; displays little to no activity against p110β/γ/δ (IC50>3,000 nM), as well as class-III PI3Ks, mTOR, DNA-PK, and PI4Kα/β; induces reduction in focus formation CEF by the highly transforming iSH2 mutants KS459delN, DKRMNS560del, and K379E, blocks PI3K signalling and tumour growth in certain cell types.
  • Synonyms
    A 66; A-66
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    p110α;p110γ;p110δ;PI3Kβ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1166227-08-2
  • Formula Weight
    393.52
  • Molecular Formula
    C17H23N5O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(N1[C@H](C(N)=O)CCC1)NC2=NC(C)=C(C3=CSC(C(C)(C)C)=N3)S2
  • Chemical Name
    1,2-Pyrrolidinedicarboxamide, N1-[2-(1,1-dimethylethyl)-4'-methyl[4,5'-bithiazol]-2'-yl]-, (2S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jamieson S, et al. Biochem J. 2011 Aug 15;438(1):53-62.
2. Sun M, et al. Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15547-52.
3. Weigelt B, et al. Clin Cancer Res. 2013 Jul 1;19(13):3533-44.
molnova catalog
related products
  • Palosuran hydrochlor...

    Palosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6±0.2 nM.

  • CL27c

    CL27c is a cell-permeable, inhaled lipophilic ester prodrug of CL27e, which is a potent, selective pan-class I PI3K inhibitor, CL27c is inactive in PI3K enzymatic assay.

  • hSMG-1 inhibitor 11j

    hSMG-1 inhibitor 11j is a pyrimidine derivative. hSMG-1 inhibitor 11j is a potent and selective inhibitor of hSMG-1, IC50 = 0.11 nM.